"Kannarr Eye Care is a full service eye and vision care provider, accepting both eye emergencies as well as scheduled appointments. Patients throughout the four state area come to Kannarr Eye Care because they know they will receive the personal attention, professional care, and advanced technology that is our foundation. We are dedicated to keeping our patients comfortable and well-informed at all times. At Kannarr Eye Care, we will explain every exam and procedure and answer all of our patients' questions. Additionally, at Kannarr Eye Care, we offer vision financing options and will work with vision and health insurance providers to ensure good eye health and vision care for all of our patients."

During the past decade, Kannarr Eye Care conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 24 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 20 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kannarr Eye Care" #1 sponsor was "Johnson & Johnson Vision Care, Inc." with 14 trials, followed by "Coopervision, Inc." with 5 trials sponsored, "SightGlass Vision, Inc." with 4 trials sponsored, "Allergan" with 2 trials sponsored and "RVL Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kannarr Eye Care" #1 collaborator was "Alcon Research" with 1 trials as a collaborator, "Bausch & Lomb Incorporated" with 1 trials as a collaborator, "Coopervision, Inc." with 1 trials as a collaborator and "Visioncare Research Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Kannarr Eye Care" are "Visual Acuity" (12 trials), "Myopia" (6 trials), "Dry Eye" (4 trials), "Juvenile Myopia" (4 trials) and "Presbyopia" (3 trials). Many other conditions were trialed in "Kannarr Eye Care" in a lesser frequency.

Most popular intervention types in "Kannarr Eye Care" are "Device" (26 trials), "Drug" (11 trials), "Other" (5 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Novel spectacle lens design" (3 trials), "Placebo" (3 trials), "Spectacle lenses" (3 trials), "Vehicle" (3 trials) and "PVP-I 0.6%" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kannarr Eye Care" are 37 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kannarr Eye Care". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 30 completed trials in Kannarr Eye Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kannarr Eye Care, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 25 trials that are defined as “Not Applicable".